Ultragenyx Net Borrowings vs Free Cash Flow Analysis

RARE Stock  USD 46.55  2.31  4.73%   
Ultragenyx financial indicator trend analysis is much more than just breaking down Ultragenyx prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ultragenyx is a good investment. Please check the relationship between Ultragenyx Net Borrowings and its Free Cash Flow accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ultragenyx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.

Net Borrowings vs Free Cash Flow

Net Borrowings vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ultragenyx Net Borrowings account and Free Cash Flow. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Ultragenyx's Net Borrowings and Free Cash Flow is -0.56. Overlapping area represents the amount of variation of Net Borrowings that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Ultragenyx, assuming nothing else is changed. The correlation between historical values of Ultragenyx's Net Borrowings and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Borrowings of Ultragenyx are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of Net Borrowings i.e., Ultragenyx's Net Borrowings and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.56
Relationship DirectionNegative 
Relationship StrengthVery Weak

Net Borrowings

The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
Most indicators from Ultragenyx's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ultragenyx current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ultragenyx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.The current year's Selling General Administrative is expected to grow to about 325.3 M, whereas Tax Provision is projected to grow to (1.7 M).
 2021 2022 2023 2024 (projected)
Reconciled Depreciation13.2M18.2M26.0M16.3M
Interest Income1.9M11.1M26.7M28.0M

Ultragenyx fundamental ratios Correlations

0.820.840.770.70.74-0.74-0.820.690.770.840.170.760.950.660.930.960.740.950.890.770.710.960.930.680.92
0.821.00.460.960.97-0.44-0.990.950.490.970.480.930.70.940.790.870.960.780.980.980.960.730.810.960.77
0.841.00.470.960.97-0.46-0.990.950.50.980.480.930.720.920.80.880.960.80.980.980.960.740.810.950.79
0.770.460.470.230.29-0.86-0.420.220.860.5-0.160.410.890.260.720.660.280.760.610.320.250.870.720.210.73
0.70.960.960.230.99-0.29-0.960.980.340.930.60.890.550.970.650.761.00.640.90.990.980.580.670.990.66
0.740.970.970.290.99-0.29-0.970.970.350.960.570.950.60.940.690.80.990.710.920.991.00.610.710.990.71
-0.74-0.44-0.46-0.86-0.29-0.290.4-0.2-1.0-0.440.16-0.3-0.82-0.31-0.6-0.58-0.34-0.63-0.55-0.37-0.24-0.85-0.6-0.22-0.57
-0.82-0.99-0.99-0.42-0.96-0.970.4-0.96-0.45-0.98-0.54-0.93-0.68-0.95-0.8-0.89-0.97-0.79-0.97-0.98-0.96-0.7-0.82-0.96-0.76
0.690.950.950.220.980.97-0.2-0.960.250.920.580.880.530.930.690.780.970.670.90.970.970.560.710.980.7
0.770.490.50.860.340.35-1.0-0.450.250.49-0.110.360.850.360.630.620.390.660.60.420.30.870.630.270.61
0.840.970.980.50.930.96-0.44-0.980.920.490.550.960.720.90.80.890.940.820.970.950.950.720.810.930.77
0.170.480.48-0.160.60.570.16-0.540.58-0.110.550.52-0.030.640.170.280.570.160.430.550.60.00.190.610.15
0.760.930.930.410.890.95-0.3-0.930.880.360.960.520.650.860.710.820.90.750.910.910.950.620.730.920.71
0.950.70.720.890.550.6-0.82-0.680.530.850.72-0.030.650.50.870.870.60.920.80.630.560.990.860.520.91
0.660.940.920.260.970.94-0.31-0.950.930.360.90.640.860.50.640.740.950.590.890.950.940.550.670.960.59
0.930.790.80.720.650.69-0.6-0.80.690.630.80.170.710.870.640.960.680.920.870.710.660.891.00.650.89
0.960.870.880.660.760.8-0.58-0.890.780.620.890.280.820.870.740.960.790.960.930.820.780.880.960.760.89
0.740.960.960.281.00.99-0.34-0.970.970.390.940.570.90.60.950.680.790.690.911.00.980.630.70.980.71
0.950.780.80.760.640.71-0.63-0.790.670.660.820.160.750.920.590.920.960.690.870.720.680.90.920.640.9
0.890.980.980.610.90.92-0.55-0.970.90.60.970.430.910.80.890.870.930.910.870.930.90.820.880.890.84
0.770.980.980.320.990.99-0.37-0.980.970.420.950.550.910.630.950.710.821.00.720.930.980.660.730.980.73
0.710.960.960.250.981.0-0.24-0.960.970.30.950.60.950.560.940.660.780.980.680.90.980.570.680.990.68
0.960.730.740.870.580.61-0.85-0.70.560.870.720.00.620.990.550.890.880.630.90.820.660.570.880.540.91
0.930.810.810.720.670.71-0.6-0.820.710.630.810.190.730.860.671.00.960.70.920.880.730.680.880.670.89
0.680.960.950.210.990.99-0.22-0.960.980.270.930.610.920.520.960.650.760.980.640.890.980.990.540.670.65
0.920.770.790.730.660.71-0.57-0.760.70.610.770.150.710.910.590.890.890.710.90.840.730.680.910.890.65
Click cells to compare fundamentals

Ultragenyx Account Relationship Matchups

Ultragenyx fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.1B1.8B1.5B1.5B1.5B856.5M
Other Current Liab83.2M140.9M134.5M192.9M225.7M237.0M
Total Current Liabilities103.3M189.6M181.4M261.2M280.4M294.5M
Total Stockholder Equity653.8M1.2B922.6M352.5M275.4M481.1M
Other Liab348.7M376.3M387.6M911.9M1.0B1.1B
Property Plant And Equipment Net74.7M114.0M176.2M285.7M290.6M305.1M
Net Debt(396.6M)(665.3M)(265.6M)(101.4M)(170.4M)(178.9M)
Retained Earnings(1.4B)(1.6B)(2.1B)(2.8B)(3.4B)(3.2B)
Accounts Payable12.9M12.9M17.1M43.3M42.1M44.2M
Cash433.6M713.5M307.6M132.9M213.6M202.9M
Non Current Assets Total284.5M464.3M665.8M661.5M758.8M796.8M
Non Currrent Assets Other(4.2M)(24.5M)11.6M10.7M57.7M60.6M
Other Assets3.5M8.8M20.6M16.8M19.4M20.3M
Cash And Short Term Investments760.4M1.2B999.1M896.7M577.2M543.4M
Net Receivables32.8M23.1M28.4M40.4M73.4M77.1M
Common Stock Total Equity58K67K69K70K80.5K44.1K
Common Stock Shares Outstanding56.6M60.8M67.8M69.9M73.5M50.9M
Liabilities And Stockholders Equity1.1B1.8B1.5B1.5B1.5B856.5M
Non Current Liabilities Total378.4M415.6M418.5M931.7M935.2M981.9M
Other Current Assets46.2M57.6M71.7M68.9M47.6M34.5M
Other Stockholder Equity2.1B2.8B3.0B3.1B3.7B3.8B
Total Liab481.7M605.2M599.8M1.2B1.2B1.3B
Property Plant And Equipment Gross74.7M114.0M226.2M349.1M374.0M392.7M
Total Current Assets851.0M1.3B856.6M883.9M732.2M564.7M
Accumulated Other Comprehensive Income(147K)689K(1.4M)(6.6M)647K679.4K
Common Stock58K67K69K70K82K47.6K
Property Plant Equipment74.7M73.5M141.2M259.7M298.7M313.6M
Short Term Investments321.6M488.0M432.6M614.8M363.6M347.3M
Net Tangible Assets480.4M978.9M758.4M148.0M170.2M161.7M
Retained Earnings Total Equity(1.4B)(1.6B)(2.1B)(2.8B)(2.5B)(2.4B)
Capital Surpluse2.1B2.8B3.0B3.1B3.6B2.0B
Inventory11.5M13.0M16.2M26.8M34.0M35.7M
Non Current Liabilities Other345.1M382.3M385.2M4.8M12.2M11.6M
Intangible Assets129M131.1M130.8M160.1M166.3M108.7M
Long Term Investments32.9M10.5M258.9M154.5M199.9M108.0M
Net Invested Capital653.8M1.2B922.6M352.5M275.4M497.3M
Net Working Capital747.7M1.1B675.2M622.7M451.7M667.7M
Capital Stock58K67K69K70K82K72.8K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ultragenyx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultragenyx. If investors know Ultragenyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultragenyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.35)
Revenue Per Share
6.015
Quarterly Revenue Growth
0.423
Return On Assets
(0.24)
Return On Equity
(2.90)
The market value of Ultragenyx is measured differently than its book value, which is the value of Ultragenyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ultragenyx's value that differs from its market value or its book value, called intrinsic value, which is Ultragenyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultragenyx's market value can be influenced by many factors that don't directly affect Ultragenyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultragenyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultragenyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultragenyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.